Kali-Extracts and Nouveau Announce Cannabis Extraction Partnership For Canadian Recreational Marijuana Market
21 Dezember 2018 - 7:52PM
InvestorsHub NewsWire
Kali-Extracts and Nouveau
Announce Cannabis Extraction Partnership For Canadian Recreational
Marijuana Market
DALLAS, TX -
December 21, 2018 -- InvestorsHub NewsWire
-- Kali, Inc. (dba/Kali-Extracts, Inc.)
(USOTC:
KALY) (“KALY”) today announced plans with Nouveau Life
Pharmaceuticals (USOTC:
NOUV) to use KALY’s patented cannabis extraction process in
Canada. NOUV has a cannabis cultivation business with
operations in the U.S. and Canada. The two companies will
work together to produce cannabis extracts utilizing KALY’s
patented cannabis extraction process for the recreational marijuana
market.
KALY currently produces pharmaceutical
grade cannabis extracts that have been involved in multiple
clinical trials in addition to utilizing its patented cannabis
extraction process in the production of CBD infused nutrition and
wellness products to include its own Hemp4mula and CBD infused
waters produced by Puration, Inc. (USOTC: PURA)
(“PURA”).
KALY is partners with PURA and NOUV in a
joint venture named US Cannabis Health for the purpose of together
developing partnerships with pharmaceutical companies to develop
cannabis pharmaceuticals. US Cannabis Health recently
announced its first agreement with Generex Biotechnology, Corp.
(OTCQB: GNBT).
To learn more about the KALY and NOUV
project announced today, follow developments online at www.kali-extracts.com.
Disclaimer/Safe
Harbor:
This news release contains forward-looking statements within the
meaning of the Securities Litigation Reform Act. The statements
reflect the Company's current views with respect to future events
that involve risks and uncertainties. Among others, these risks
include the expectation that any of the companies mentioned herein
will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the
companies' liquidity position, the companies' ability to obtain new
contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur. These statements have not been evaluated
by the Food and Drug Administration. These products are not
intended to diagnose, treat, cure, or prevent any
disease.
Kali,
Inc.
Frederick Ferri
ir@kali-extracts.com
(214)
210-0459
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Nouveau Life Pharmaceuticals Inc (PK) (OTCMarkets): 0 Nachrichtenartikel
Weitere Nouveau Life Pharmaceuticals, Inc. (PN) News-Artikel